MPG Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 306 amino acids (1-298 a.a.) and having a molecular mass of 33.9kDa (Molecular weight on SDS-PAGE will appear higher).
MPG is fused to an 8 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
DNA-3-methyladenine glycosylase, 3-alkyladenine DNA glycosylase, 3-methyladenine DNA glycosidase, ADPG, N-methylpurine-DNA glycosylase, MPG, AAG, ANPG, MID1, MDG, PIG11, PIG16, CRA36.1.
MVTPALQMKK PKQFCRRMGQ KKQRPARAGQ PHSSSDAAQA PAEQPHSSSD AAQAPCPRER CLGPPTTPGP YRSIYFSSPK GHLTRLGLEF FDQPAVPLAR AFLGQVLVRR LPNGTELRGR IVETEAYLGP EDEAAHSRGG RQTPRNRGMF MKPGTLYVYI IYGMYFCMNI SSQGDGACVL LRALEPLEGL ETMRQLRSTL RKGTASRVLK DRELCSGPSK LCQALAINKS FDQRDLAQDE AVWLERGPLE PSEPAVVAAA RVGVGHAGEW ARKPLRFYVR GSPWVSVVDR VAEQDTQALE HHHHHH.
N-methylpurine-DNA glycosylase (MPG), also known as 3-alkyladenine DNA glycosylase or AAG, is a critical DNA repair enzyme that excises damaged purine bases from DNA. It specifically recognizes and removes alkylated DNA bases, playing an essential role in the base excision repair (BER) pathway. MPG functions by cleaving the N-glycosidic bond between the damaged base and the deoxyribose sugar, creating an abasic site that is subsequently processed by downstream BER enzymes . This repair mechanism is particularly important for maintaining genomic integrity against various alkylating agents that can damage DNA.
Studies have shown that MPG expression is not uniform across human tissues. Notably, altered expression of MPG has been observed in human gonads compared to other tissues, suggesting tissue-specific regulation and potentially specialized functions in reproductive cells . Research has also identified differential expression patterns in certain pathological states, including various cancer types, indicating that MPG expression may be regulated in a tissue- and context-dependent manner. To accurately assess MPG expression across tissues, quantitative PCR, western blotting, and immunohistochemistry are recommended methodological approaches.
Human MPG recognizes and processes a variety of DNA lesions, particularly those resulting from alkylation damage. Primary substrates include 3-methyladenine, 7-methylguanine, and various etheno adducts. Research has demonstrated that 3,N4-ethenocytosine, a highly mutagenic adduct, serves as a primary substrate for MPG alongside other DNA glycosylases . Substrate specificity studies are typically conducted using purified enzyme with synthesized oligonucleotides containing specific DNA lesions, followed by cleavage assays to determine excision efficiency.
MPG functions primarily within the base excision repair pathway but demonstrates significant cross-talk with other DNA repair mechanisms. Research indicates potential interactions between MPG and mismatch repair proteins, as evidenced by studies examining expression patterns of DNA repair proteins including hMSH2, hMSH6, hMLH1, and MPG in melanoma cells with acquired drug resistance . These interactions suggest a complex network of DNA repair mechanisms that can compensate for or complement MPG activity.
When designing experiments to investigate these interactions, researchers should consider:
Co-immunoprecipitation assays to detect protein-protein interactions
CRISPR-Cas9 knockout/knockdown of MPG combined with functional assays of other repair pathways
Synthetic lethality screens to identify genes with functional relationships to MPG
MPG has been implicated in both cancer susceptibility and therapeutic response. Studies have demonstrated altered expression of MPG in melanoma cells with acquired drug resistance, suggesting a potential role in chemoresistance mechanisms . Additionally, research on human glioma cell sensitivity to sequence-specific alkylating agents indicates that MPG activity levels may influence tumor cell response to alkylating chemotherapeutics .
For researchers investigating MPG in cancer contexts, recommended approaches include:
Analysis of MPG expression in paired drug-sensitive and drug-resistant cell lines
Correlation of MPG activity with response to alkylating agents in patient-derived samples
Development of combination therapies that target both MPG and complementary DNA repair pathways
Novel genetic polymorphisms in MPG have been identified in lung cancer patients, suggesting potential impacts on repair capacity and disease susceptibility . These genetic variants may alter enzyme activity, substrate specificity, or protein stability, thereby influencing an individual's capacity to repair specific types of DNA damage.
When studying MPG polymorphisms, researchers should:
Employ genotyping methodologies to identify variants in patient populations
Use in vitro enzyme activity assays to characterize functional consequences of variants
Develop cell models expressing different MPG variants to assess repair capacity
Consider population-specific polymorphism frequencies when designing studies
To effectively measure MPG activity in vitro, researchers typically use oligonucleotide substrates containing specific lesions. A comprehensive approach should include:
Enzyme Purification: Express recombinant human MPG in bacterial or eukaryotic systems, followed by affinity purification.
Substrate Preparation: Synthesize oligonucleotides containing specific DNA lesions (e.g., 3-methyladenine, 7-methylguanine, εA, εC).
Activity Assays: Incubate purified enzyme with labeled substrates and analyze cleavage products by gel electrophoresis.
Kinetic Analysis: Determine enzyme kinetics (Km, Vmax) under varying conditions to understand catalytic properties.
These approaches allow for precise characterization of MPG activity, substrate preference, and the impact of experimental conditions on enzyme function.
Several methodological approaches can be employed to manipulate MPG expression or activity for functional studies:
Genetic Approaches:
CRISPR-Cas9 for gene knockout or knock-in of specific variants
siRNA or shRNA for transient or stable knockdown
Overexpression vectors for increased MPG levels
Chemical Approaches:
Small molecule inhibitors (though few specific MPG inhibitors are currently available)
Alkylating agents to induce MPG substrate formation
Functional Validation:
Comet assay to measure DNA damage repair capacity
Cell survival assays following exposure to alkylating agents
Immunofluorescence to track MPG localization during DNA damage response
When investigating MPG in chemical biology contexts, researchers should consider several key factors:
Compound Selectivity: Ensure compounds designed to interact with MPG don't affect other DNA glycosylases or repair proteins.
Structure-Activity Relationships: Chemical biology approaches, such as those employed by the Department of Chemical Biology at the Max-Planck-Gesellschaft, can be valuable for developing compounds that modulate MPG activity .
Cell Permeability: Design compounds with appropriate physicochemical properties to reach nuclear targets.
Cellular Specificity: Consider using targeted delivery systems for cell- or tissue-specific modulation of MPG activity.
MPG research has significant implications for cancer therapeutics, particularly for tumors treated with alkylating agents. Studies of human glioma cell sensitivity to sequence-specific alkylating agents like methyl-lexitropsin highlight the importance of understanding MPG function in treatment response . Researchers exploring translational applications should:
Develop Biomarkers: Establish MPG expression or activity as potential predictive biomarkers for response to alkylating chemotherapeutics.
Target Synthetic Lethality: Identify pathways that, when inhibited alongside MPG, create synthetic lethality in cancer cells.
Consider Combination Therapy: Design treatment strategies that combine alkylating agents with modulators of MPG activity to enhance therapeutic efficacy.
Expression patterns of DNA repair proteins, including MPG, hMSH2, hMSH6, hMLH1, and O6-methylguanine-DNA methyltransferase, have been studied in melanoma cells with acquired drug resistance . These studies suggest complex interactions between different repair pathways in mediating therapeutic resistance. When investigating these relationships, researchers should:
Profile Multiple Repair Pathways: Simultaneously analyze expression and activity of proteins from different repair pathways.
Use Multi-drug Models: Develop resistance models with different classes of DNA-damaging agents.
Employ Systems Biology: Apply network analysis to understand how alterations in multiple repair pathways contribute to resistance phenotypes.
While MPG primarily refers to N-methylpurine-DNA glycosylase in human systems, it's important to note that MPG peptides, such as MPG peptides Pβ, represent a distinct research area. These primary amphiphilic peptides consisting of three domains should not be confused with the DNA repair enzyme. Researchers should be careful to clearly differentiate between these entities in their experimental design and reporting.
Accurate measurement of MPG activity in biological samples presents several technical challenges:
Specificity: Multiple glycosylases may act on similar substrates, complicating attribution of activity specifically to MPG.
Low Abundance: MPG may be present at low levels in certain tissues, requiring sensitive detection methods.
Posttranslational Modifications: MPG activity can be regulated by PTMs that may be lost during sample processing.
To address these challenges, researchers should consider:
Using MPG-specific antibodies for activity depletion studies
Developing highly sensitive fluorescence-based activity assays
Preserving sample integrity through careful handling and processing
When faced with contradictory findings regarding MPG function, researchers should systematically:
Compare Methodological Differences: Assess differences in experimental systems, assay conditions, and cell types used across studies.
Consider Context-Dependency: Evaluate whether contradictions might reflect true biological variability across different contexts.
Perform Validation Studies: Design experiments that directly address contradictions using multiple complementary approaches.
Assess Reagent Quality: Verify antibody specificity, enzyme purity, and cell line authenticity across studies.
When analyzing MPG data, researchers should employ appropriate statistical methods based on experimental design:
For Expression Studies:
Use non-parametric tests when sample sizes are small or normality cannot be assumed
Apply multiple testing correction for genome-wide or proteome-wide analyses
Consider ANOVA for multi-group comparisons with post-hoc tests
For Activity Assays:
Use regression analysis for enzyme kinetics data
Apply appropriate transformations for non-linear relationships
Consider mixed-effects models when analyzing data with multiple sources of variation
For Clinical Correlations:
Use multivariate regression to account for confounding variables
Consider survival analysis methods for outcome-related studies
Validate findings in independent cohorts when possible
MPG plays a pivotal role in maintaining genomic stability by removing alkylated and deaminated purines from DNA. The enzyme recognizes and excises a variety of damaged bases, including hypoxanthine, xanthine, uracil, and thymine . The excision of these bases is the first step in the BER pathway, which is essential for repairing DNA damage and preventing mutations .
The intrinsic kinetic parameters (kcat and Km) for the excision of hypoxanthine by the recombinant human MPG protein have been determined, revealing that the differences in specificity are primarily in product release rather than binding . The MPG protein forms a strong complex with the product of excision, an abasic site, as well as with a reduced abasic site .
MPG is a monofunctional glycosylase, meaning it only performs the glycosylase activity without associated lyase activity. The enzyme binds to damaged DNA and cleaves the N-glycosidic bond, releasing the damaged base and leaving an abasic site . The MPG protein protects a specific region of the DNA strand, indicating a precise interaction with its target .
The removal of damaged bases by MPG is critical for preventing cytotoxicity and mutagenesis. Alkylating agents, a subclass of DNA-damaging agents, introduce N-methylpurines into DNA, which can be cytotoxic or premutagenic if left unrepaired . By excising these damaged bases, MPG helps to maintain the integrity of the genome and prevent the accumulation of mutations .